CClinicalTrials.gg
Status unknownNCT01841866Updated Jul 31, 2019

Laryngeal Mask Airway Removal During Deep Anesthesia in Children

An interventional study of LMA removal in Post Operative Sore Throat After LMA Removal, sponsored by Prince of Songkla University. Status unknown at 1 site in Thailand. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2019-07-31.

Sponsored by Prince of Songkla University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
456
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Laryngeal mask airway (LMA) is widely used in children.The appropriate time to remove laryngeal mask airway is still inconclusive.Sore throat is one of common complications after general anesthesia. Sometimes postoperative sore throat affects patients' satisfaction and daily activities. It can be correlated with dysphagia and may limit oral intake especially in children.The incidence of postoperative sore throat after laryngeal mask airway insertion varies from 5.8-34% in adult(13) and 17.5% in pediatric.Somehow, almost the studies of postoperative sore throat after laryngeal mask airway removal were done in awake state. Our study object to test that post operative sore throat after LMA removal in deep anesthetized children is lower than awake children.

Read the detailed description

Patients age between 6-12 years who have ASA physical status I-II and scheduled for elective surgery will be enrolled in this study and randomly assigned into two groups (group A = awake group and group D = deep anesthetized group) by using computer-generated randomization table. The patients who have the following problems: active airway disease, risk of aspiration, intra-peritoneal or airway surgery will be excluded.

At the day of surgery, demographic data will be recorded by nurse anesthetist. Visual analog scale (VAS) will be used as a tool for evaluating preoperative sore throat.

At the operating room, after standard monitoring and pre-oxygenated with 100% oxygen via tight anesthetic face mask for 5 minutes. Propofol (3-5 mg/kg) and fentanyl(1-3 ug/kg) will be used for induction. After the patient is apnea and loss of eyelash reflex, appropriate size of classic LMA ,which is prepared by fully deflated to forms a smooth "spoon-shape" and be lubricated by water based jelly, will be applied with standard LMA insertion technique. Once LMA is in the right position, air will be inflated to the cuff of LMA, for keeping cuff pressure between 40-60 cmH2O. Air, O2 and Sevoflurane ≥ 1minimal alveolar concentration (MAC) will be used to keep the patient anesthetized. Performer of LMA insertion and number of insertion attempts will be recorded.

At the end of surgery, LMA will be removed with the technique which is followed by the group assignment, group D and group A. After that, patient will be transferred to post anesthetic care unit (PACU).

At PACU, After the patient is fully awake, the blind investigator will ask the patient to evaluate post operative sorethroat by using Visual analog scale (VAS) (0-10). Dysphagia (discomfort when swallowing) using dysphagia score (0 = able to eat normal diet / no dysphagia, 1 = able to swallow some solid foods, 2 = able to swallow only semi solid foods, 3 = able to swallow liquids only, 4 = unable to swallow anything / total dysphagia), dysphonia (discomfort when speaking such as hoarseness) using dysphonia score (0 = no hoarseness, 1 = mild/no hoarseness in the time of interview but had it previously, 2 = moderate/only is felt by the patient or their parents, 3 = severe/recognizable in the time of interview) Any adverse events will be evaluated at 1 hour in PACU. Then the evaluation will be repeated by telephoned interview at 24 and 72 hours respectively.

02

Conditions studied

  • Post Operative Sore Throat After LMA Removal

Browse trials for

Keywords

  • post operative sore throat
  • laryngeal mask airway
  • children
03

In context

Pharyngitis

252 studies on the registry are indexed under Pharyngitis; 36 are open to participants now.

This study's planned enrollment of 456 is above the median of 144 across 209 interventional studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Prince of Songkla University is the lead sponsor of 112 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 6-12 years
  • ASA physical status I-II
  • elective surgery

Exclusion criteria

Exclusion Criteria:

  • active airway disease
  • risk for aspiration
  • intraperitoneal or airway surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
456 participants (estimated)

Study arms

  • Active comparator
    deep anesthetic state

    LMA removal

    Other: LMA removal

  • Placebo comparator
    awake

    LMA removal

    Other: LMA removal

Interventions

  • OtherLMA removal
06

What researchers measure

Primary outcomes

  1. Incidence of Postoperative Sorethroat

    Evaluate post operative sorethroat by using Visual analog scale (VAS) (0-10)

    Time frame: upto 72 hr post operative period

Secondary outcomes

  1. Dysphagia

    Dysphagia (discomfort when swallowing) by using Visual analog scale (VAS) (0-10) dysphagia score 0 = able to eat normal diet / no dysphagia 1. = able to swallow some solid foods 2. = able to swallow only semi solid foods 3. = able to swallow liquids only 4. = unable to swallow anything / total dysphagia

    Time frame: upto 72 hr postoperative period

  2. Dysphonia

    dysphonia (discomfort when speaking such as hoarseness) by using numerical rating scale (VAS) (0-10) dysphonia score 0= no hoarseness 1. = mild/no hoarseness in the time of interview but had it previously 2. = moderate/only is felt by the patient or their parents 3. = severe/recognizable in the time of interview

    Time frame: upto 72 hr postoperative period

  3. Adverse event: teeth or mucosal trauma

    Yes /no

    Time frame: upto 72 hr postoperative period

  4. laryngospasm

    yes/ no

    Time frame: Intraoperative and PACU period

  5. Bronchospasm

    yes/no

    Time frame: Intraoperative and PACU period

  6. Desaturation

    Oxygen saturation less than 95%

    Time frame: Intraoperative and PACU period

  7. Nausea and vomiting

    using numerical rating scale (VAS) (0-10) as a measurement tool

    Time frame: up to 72 hr postoperative period

  8. cough

    Mild: \< 10 times per day Moderate 10-20 times per day Severe \> 20 times per day

    Time frame: up to72 hr postoperative period

07

Study locations

1 of 1 sites recruiting
  • Prince of Songkla University
    Hat Yai, Songkhla 90110, Thailand
    • Ngamjit Pattaravit, MD. · Contact · ngamjitp@yahoo.com · 66897001350
    • Ngamjit Pattaravit, MD. · Principal investigator
    • Kamonwan Limpadapan, MD. · Sub investigator
    • Thavat Chanchayanon, MD. · Sub investigator
    • Wirat Wasinwong, MD. · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01841866
Lead sponsor
Prince of Songkla University
Responsible party
Ngamjit Pattaravit (Doctor, Prince of Songkla University) — Principal investigator
First posted
Apr 29, 2013
Start date
May 2013
Primary completion
Oct 2019 (estimated)
Completion
Oct 2019 (estimated)
Last update
Jul 31, 2019

Study contacts

Ngamjit Pattaravit, MD.
Contact
ngamjitp@yahoo.com
66897001350
Kamonwan Limpadapan, MD.
Contact
wildfai@gmail.com
66813042738
Ngamjit Pattaravit, MD
principal investigator · Prince of Songkla University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion